COVID-19-related laboratory coagulation findings.
Int J Lab Hematol
; 43 Suppl 1: 36-42, 2021 Jul.
Статья
в английский
| MEDLINE | ID: covidwho-1319316
ABSTRACT
The alterations in the hemostatic balance in COVID-19 patients are strongly disturbed and contribute to a high prothrombotic status. The high rate of venous thromboembolism in COVID-19 patients goes along with derangements in coagulation laboratory parameters. Hemostasis testing has an important role in diagnosed COVID-19 patients. Elevated D-dimer levels were found to be a crucial laboratory marker in the risk assessment of thrombosis in COVID-19 patients. The diagnostic approach also includes prothrombin time and platelet count. Fibrinogen might give an indication for worsening coagulopathy. Other markers (activated partial thromboplastin time (aPTT), fibrinolysis parameters, coagulation factors, natural anticoagulants, antiphospholipid antibodies and parameters obtained by thromboelastography or thrombin generation assays) have been described as being deranged. These may help to understand the pathophysiology of thrombosis in COVID-19 patients but have currently no place in diagnosis or management in COVID-19 patients. For monitoring the heparin anticoagulant therapy, the anti-Xa assay is suggested, because the severe acute-phase reaction (high fibrinogen and high factor VIII) shortens the aPTT.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Blood Coagulation Tests
/
Thrombophilia
/
SARS-CoV-2
/
COVID-19
Тип исследования:
Диагностическое исследование
/
Прогностическое исследование
Пределы темы:
Люди
Язык:
английский
Журнал:
Int J Lab Hematol
Тематика журнала:
Гематология
Год:
2021
Тип:
Статья
Аффилированная страна:
Ijlh.13547
Документы, близкие по теме
MEDLINE
...
LILACS
LIS